{"url_path":"/sec/tyra/8-k/2026-06-02/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 Submission of Matters to a Vote of Security Holders.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-02","source_url":"https://www.sec.gov/Archives/edgar/data/1863127/0001193125-26-253435-index.html","accession_number":"0001193125-26-253435","cik":"0001863127","ticker":"TYRA","issuer_name":"Tyra Biosciences, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1863127/0001193125-26-253435-index.html","primary_entity_key":"0001863127","primary_entity_name":"Tyra Biosciences, Inc."},"word_count":227,"has_tables":true,"body_markdown":"Item 5.07\n\nSubmission of Matters to a Vote of Security Holders.\n\nTyra Biosciences, Inc. (the Company) held its 2026 Annual Meeting of Stockholders (the 2026 Annual Meeting) on May 28, 2026. The following is a brief description of each matter voted upon at the 2026 Annual Meeting and the number of votes cast for, withheld or against, the number of abstentions and the number of broker non-votes with respect to each matter, as applicable.\n\n \n\n \n1.\n\nThe election of three directors to serve as Class II directors for a three-year term to expire at the 2029 Annual Meeting of Stockholders. The following three Class II directors were elected by the votes indicated:\n\n \n\n \n  \nFor\n \n  \nWithheld\n \n  \nBroker Non-Votes\n \n\nHabib J. Dable\n\n  \n \n44,242,803\n \n  \n \n476,602\n \n  \n \n8,377,977\n \n\nSusan Moran, M.D., M.S.C.E.\n\n  \n \n44,529,688\n \n  \n \n189,717\n \n  \n \n8,377,977\n \n\nRobert More\n\n  \n \n41,013,686\n \n  \n \n3,705,719\n \n  \n \n8,377,977\n \n\n \n\n2.\n\nThe ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The appointment was ratified by the votes indicated:\n\n \n\nFor\n\n \n\nAgainst\n\n \n\nAbstain\n\n \n\nBroker Non-Votes\n\n53,092,820\n \n1,316\n \n3,246\n \n–\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \nTYRA BIOSCIENCES, INC.\n\nDate: June 2, 2026\n\n \n\n \nBy:\n \n\n/s/ Ali Fawaz\n\n \n\n \nName:\n \nAli Fawaz\n\n \n\n \nTitle:\n \nGeneral Counsel and Secretary"}